Previous Close | 0.5700 |
Open | 0.5600 |
Bid | 0.5100 x N/A |
Ask | 0.6000 x N/A |
Day's Range | 0.5600 - 0.5900 |
52 Week Range | 0.0150 - 0.6300 |
Volume | |
Avg. Volume | 37,718 |
Market Cap | 84.444M |
Beta (5Y Monthly) | 1.48 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2600 |
Earnings Date | May 13, 2024 - May 17, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.99 |
Key Takeaways; Cannabis Sector Canopy Growth received ISS recommendation for creation of exchangeable shares. Trulieve to hold first quarter 2024 results conference call at the beginning of May. Goodness Growth announced sale of Vireo Health of New York in effort to address financial constraints. Avant Brands entered German market through IM Cannabis deal. Key Takeaways; […]
– Led by Steven Acevedo and Art Isagholian, ACE Venture Enterprises, Inc., a minority-owned business, plans to acquire Vireo Health of New York to accelerate entry into the New York market – – Ace plans to retain Goodness Growth with a collaborative advisory agreement to advance the long-term success of both organizations – – Terms include a purchase price of between $3 to $5 million, an investment of $20 million from Ace for development of the Johnstown cultivation and manufacturing campus, and
– Company demonstrates improved performance with record revenue and operating income in fiscal year 2023 – – Q4 2023 revenue of $24.2 million excluding discontinued operations increased 34.4% year-over-year – – Q4 2023 operating income of $5.4 million, the second consecutive quarter above $5 million – MINNEAPOLIS, April 01, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access,